Skip to content

Risk factor analysis of postoperative hypoalbuminemia in malignant tumor patients

Risk factor analysis of postoperative hypoalbuminemia in malignant tumor patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078604
Enrollment
Unknown
Registered
2023-12-13
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoproteinemia

Interventions

Hypoproteinemia group: ALB<35g/L (Part 1):This part of the experiment is risk factor analysis, no intervention measures. Preoperative data of patients were collected for risk factor analysis.
Normal group ALB = 35g/L(Part 1):This part of the experiment is risk factor analysis, no intervention measures. Preoperative data of patients were collected for risk factor analysis.
General anesthesia group (Part 2):The patient received general anesthesia and a postoperative intravenous self-controlled analgesic pump (dispensing method: 1ug/kg.d sufentanil, the total amount is co
Compound epidural anesthesia group (Part 2):The patient received general anesthesia combined with epidural anesthesia. Before general anesthesia, epidural puncture and epidural catheter were placed. T

Sponsors

The First Affiliated Hospital of Nanjing Medical University in Huai'an
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Part 1: Patients who underwent radical surgery for malignant tumors in our hospital, aged = 18 years, regardless of gender or race, normal liver function before surgery, and no long-term history of taking drugs with obvious liver damage. All subjects signed informed consent forms. Part II: Patients who underwent radical surgery for malignant tumors in our hospital, aged = 18 years, regardless of gender or race, normal liver function before surgery, and no long-term history of taking drugs with obvious liver damage. All subjects signed informed consent.

Exclusion criteria

Exclusion criteria: Part 1: Age < 18 years old, emergency surgery, patients with acute or chronic hepatitis activity, pregnancy status, postoperative clear drug-induced liver injury, autoimmune diseases, preoperative abnormal liver function, contraindications to epidural anesthesia, those with abnormal preoperative risk factors related to hypoalbuminemia, and incomplete clinical data. Patients who explicitly refused to participate in the experiment. Part II: Age < 18 years old, emergency surgery, patients with acute or chronic hepatitis activity, pregnancy status, postoperative clear drug-induced liver injury, autoimmune diseases, preoperative abnormal liver function, contraindications to epidural anesthesia, those with abnormal preoperative risk factors related to hypoalbuminemia, and incomplete clinical data. Patients who explicitly refused to participate in the experiment.

Design outcomes

Primary

MeasureTime frame
Serum albumin;

Secondary

MeasureTime frame
Serum inflammatory factors;

Countries

China

Contacts

Public ContactZhang Zhijie

The First Affiliated Hospital of Nanjing Medical University in Huai'an

zzjwss@163.com+86 159 4917 9701

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026